Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 177

1.

An Insight on the Gold(I) Affinity of golB Protein via Multilevel Computational Approaches.

Tolbatov I, Re N, Coletti C, Marrone A.

Inorg Chem. 2019 Aug 19;58(16):11091-11099. doi: 10.1021/acs.inorgchem.9b01604. Epub 2019 Jul 29.

PMID:
31353893
2.

Hepatitis B and C virus infection and risk of haematological malignancies.

Marrone A, Ciotti M, Rinaldi L, Adinolfi LE, Ghany M.

J Viral Hepat. 2019 Jul 20. doi: 10.1111/jvh.13183. [Epub ahead of print] Review.

PMID:
31325404
3.

A snapshot of virological presentation and outcome of immunosuppression-driven HBV reactivation from real clinical practice: Evidence of a relevant risk of death and evolution from silent to chronic infection.

Salpini R, Battisti A, Colagrossi L, Di Carlo D, Fabeni L, Piermatteo L, Cerva C, Lichtner M, Mastroianni C, Marignani M, Maylin S, Delaugerre C, Morisco F, Coppola N, Marrone A, Angelico M, Sarmati L, Andreoni M, Perno CF, Ceccherini-Silberstein F, Svicher V.

J Viral Hepat. 2019 Jul;26(7):846-855. doi: 10.1111/jvh.13101. Epub 2019 May 14.

PMID:
30974483
4.

Oxidative Imbalance and Kidney Damage in Cafeteria Diet-Induced Rat Model of Metabolic Syndrome: Effect of Bergamot Polyphenolic Fraction.

La Russa D, Giordano F, Marrone A, Parafati M, Janda E, Pellegrino D.

Antioxidants (Basel). 2019 Mar 16;8(3). pii: E66. doi: 10.3390/antiox8030066.

5.

Loss of miR-17~92 results in dysregulation of Cftr in nephron progenitors.

Phua YL, Chen KH, Hemker SL, Marrone AK, Bodnar AJ, Liu X, Clugston A, Kostka D, Butterworth MB, Ho J.

Am J Physiol Renal Physiol. 2019 May 1;316(5):F993-F1005. doi: 10.1152/ajprenal.00450.2018. Epub 2019 Mar 6.

PMID:
30838872
6.

Reactivity of Gold(I) Monocarbene Complexes with Protein Targets: A Theoretical Study.

Tolbatov I, Coletti C, Marrone A, Re N.

Int J Mol Sci. 2019 Feb 14;20(4). pii: E820. doi: 10.3390/ijms20040820.

7.

Patients with HCV genotype-1 who have failed a direct-acting antiviral regimen: virological characteristics and efficacy of retreatment.

Pisaturo M, Starace M, Minichini C, De Pascalis S, Macera M, Occhiello L, Messina V, Sangiovanni V, Claar E, Precone D, Stornaiuolo G, Stanzione M, Gentile I, Brancaccio G, Martini S, Masiello A, Megna AS, Coppola C, Federico A, Sagnelli E, Persico M, Lanza AG, Marrone A, Gaeta GB, Coppola N.

Antivir Ther. 2019 Feb 13. doi: 10.3851/IMP3296. [Epub ahead of print]

PMID:
30758299
8.

Insights into the Mechanisms of Aquaporin-3 Inhibition by Gold(III) Complexes: the Importance of Non-Coordinative Adduct Formation.

Wenzel MN, Mósca AF, Graziani V, Aikman B, Thomas SR, de Almeida A, Platts JA, Re N, Coletti C, Marrone A, Soveral G, Casini A.

Inorg Chem. 2019 Feb 4;58(3):2140-2148. doi: 10.1021/acs.inorgchem.8b03233. Epub 2019 Jan 15.

PMID:
30645101
9.

A model of the three-dimensional structure of human interferon responsive factor 1 and its modifications upon phosphorylation or phosphorylation-mimicking mutations.

Storchi L, Remoli AL, Marsili G, Acchioni C, Acchioni M, Battistini A, Sgarbanti M, Marrone A.

J Biomol Struct Dyn. 2019 Oct;37(17):4632-4643. doi: 10.1080/07391102.2018.1557558. Epub 2019 Jan 19.

PMID:
30569833
10.

Effectiveness and safety of switching to entecavir hepatitis B patients developing kidney dysfunction during tenofovir.

Viganò M, Loglio A, Labanca S, Zaltron S, Castelli F, Andreone P, Messina V, Ganga R, Coppola N, Marrone A, Russello M, Marzano A, Tucci A, Taliani G, Fasano M, Fagiuoli S, Villa E, Bronte F, Santantonio T, Brancaccio G, Occhipinti V, Facchetti F, Grossi G, Rumi M, Lampertico P.

Liver Int. 2019 Mar;39(3):484-493. doi: 10.1111/liv.14017. Epub 2019 Jan 7.

PMID:
30525275
11.

Role of Tight Glycemic Control during Acute Coronary Syndrome on CV Outcome in Type 2 Diabetes.

Sasso FC, Rinaldi L, Lascar N, Marrone A, Pafundi PC, Adinolfi LE, Marfella R.

J Diabetes Res. 2018 Oct 4;2018:3106056. doi: 10.1155/2018/3106056. eCollection 2018. Review.

12.

An insight of early PrP-E200K aggregation by combined molecular dynamics/fragment molecular orbital approaches.

Paciotti R, Storchi L, Marrone A.

Proteins. 2019 Jan;87(1):51-61. doi: 10.1002/prot.25621. Epub 2018 Nov 16.

PMID:
30367504
13.

Endotoxinemia contributes to steatosis, insulin resistance and atherosclerosis in chronic hepatitis C: the role of pro-inflammatory cytokines and oxidative stress.

Zampino R, Marrone A, Rinaldi L, Guerrera B, Nevola R, Boemio A, Iuliano N, Giordano M, Passariello N, Sasso FC, Albano E, Adinolfi LE.

Infection. 2018 Dec;46(6):793-799. doi: 10.1007/s15010-018-1185-6. Epub 2018 Jul 31.

PMID:
30066228
14.

The effect of sustained virological response by direct-acting antivirals on insulin resistance and diabetes mellitus in patients with chronic hepatitis C.

Adinolfi LE, Rinaldi L, Marrone A, Giordano M.

Expert Rev Anti Infect Ther. 2018 Aug;16(8):595-597. doi: 10.1080/14787210.2018.1505500. Epub 2018 Aug 1. No abstract available.

PMID:
30047799
15.

Effect of pomegranate peel extract on shelf life of strawberries: computational chemistry approaches to assess antifungal mechanisms involved.

Rongai D, Sabatini N, Pulcini P, Di Marco C, Storchi L, Marrone A.

J Food Sci Technol. 2018 Jul;55(7):2702-2711. doi: 10.1007/s13197-018-3192-0. Epub 2018 Apr 30.

16.

Non-alcoholic fatty liver disease: beyond the liver is an emerging multifaceted systemic disease.

Adinolfi LE, Marrone A, Rinaldi L.

Hepatobiliary Surg Nutr. 2018 Apr;7(2):143-146. doi: 10.21037/hbsn.2018.02.01. No abstract available.

17.

Hematuria as an adverse outcome following provocative growth hormone stimulation testing in children.

Thirunagari R, Marrone A, Elsinghorst H, Mastrandrea LD.

J Pediatr Endocrinol Metab. 2018 Apr 25;31(5):539-543. doi: 10.1515/jpem-2017-0458.

PMID:
29688887
18.

Insight into the Electrochemical Reduction Mechanism of Pt(IV) Anticancer Complexes.

Tolbatov I, Coletti C, Marrone A, Re N.

Inorg Chem. 2018 Mar 19;57(6):3411-3419. doi: 10.1021/acs.inorgchem.8b00177. Epub 2018 Mar 6.

PMID:
29509010
19.

Hepatitis C virus eradication by direct-acting antiviral agents improves carotid atherosclerosis in patients with severe liver fibrosis.

Petta S, Adinolfi LE, Fracanzani AL, Rini F, Caldarella R, Calvaruso V, Cammà C, Ciaccio M, Di Marco V, Grimaudo S, Licata A, Marrone A, Nevola R, Pipitone RM, Pinto A, Rinaldi L, Torres D, Tuttolomondo A, Valenti L, Fargion S, Craxì A.

J Hepatol. 2018 Jul;69(1):18-24. doi: 10.1016/j.jhep.2018.02.015. Epub 2018 Mar 2.

PMID:
29505844
20.

Influence of antiviral therapy on the liver stiffness in chronic HBV hepatitis.

Rinaldi L, Ascione A, Messina V, Rosato V, Valente G, Sangiovanni V, Zampino R, Marrone A, Fontanella L, de Rosa N, Orabona P, Buonomo C, Chirianni A, Adinolfi LE, Piai G.

Infection. 2018 Apr;46(2):231-238. doi: 10.1007/s15010-017-1113-1. Epub 2018 Jan 15.

PMID:
29335905
21.

Hepatitis C virus clearance by direct-acting antiviral treatments and impact on insulin resistance in chronic hepatitis C patients.

Adinolfi LE, Nevola R, Guerrera B, D'Alterio G, Marrone A, Giordano M, Rinaldi L.

J Gastroenterol Hepatol. 2018 Jul;33(7):1379-1382. doi: 10.1111/jgh.14067. Epub 2018 Feb 27.

PMID:
29228501
22.

Eighteen-month lamivudine prophylaxis on preventing occult hepatitis B virus infection reactivation in patients with haematological malignancies receiving immunosuppression therapy.

Marrone A, Capoluongo N, D'Amore C, Pisaturo M, Esposito M, Guastafierro S, Siniscalchi I, Macera M, Boemio A, Onorato L, Rinaldi L, Minichini C, Adinolfi LE, Sagnelli E, Mastrullo L, Coppola N.

J Viral Hepat. 2018 Feb;25(2):198-204. doi: 10.1111/jvh.12802. Epub 2017 Nov 29.

PMID:
29029365
23.

A Multi-Level Theoretical Study to Disclose the Binding Mechanisms of Gold(III)-Bipyridyl Compounds as Selective Aquaglyceroporin Inhibitors.

Graziani V, Marrone A, Re N, Coletti C, Platts JA, Casini A.

Chemistry. 2017 Oct 4;23(55):13802-13813. doi: 10.1002/chem.201703092. Epub 2017 Sep 7.

PMID:
28776779
24.

The Regulatory Perspectives on Endoscopic Devices for Obesity.

Marrone AK, Antonino MJ, Silverstein JS, Betz MW, Venkataraman-Rao P, Golding M, Cordray D, Cooper JW.

Gastrointest Endosc Clin N Am. 2017 Apr;27(2):327-341. doi: 10.1016/j.giec.2016.12.004. Review.

PMID:
28292410
25.

PRES with asymptomatic spinal cord involvement. Is this scenario more common than we know?

Marrone LC, Martins WA, Brunelli JP, Fussiger H, Carvalhal GF, Filho JR, Soder RB, Schuck M, Viola FS, Marrone AC, da Costa JC.

Spinal Cord Ser Cases. 2016 Jan 7;2:15001. doi: 10.1038/scsandc.2015.1. eCollection 2016. Erratum in: Spinal Cord Ser Cases. 2016 Jul 21;2:16019.

26.

Tenofovir disoproxil fumarate monotherapy maintains HBV suppression achieved by a "de novo" combination of lamivudine-adefovir: a pilot study.

Ruggiero G, Marrone A, Rainone I, Boemio A, Adinolfi LE, Pasquale G, Rinaldi L, Guerrera B, Andreana L, Zampino R; Thecla Study Group.

Infez Med. 2016 Dec 1;24(4):278-286.

27.

The Effects of Ca2+ Concentration and E200K Mutation on the Aggregation Propensity of PrPC: A Computational Study.

Marrone A, Re N, Storchi L.

PLoS One. 2016 Dec 13;11(12):e0168039. doi: 10.1371/journal.pone.0168039. eCollection 2016.

28.

Seeking for Non-Zinc-Binding MMP-2 Inhibitors: Synthesis, Biological Evaluation and Molecular Modelling Studies.

Ammazzalorso A, De Filippis B, Campestre C, Laghezza A, Marrone A, Amoroso R, Tortorella P, Agamennone M.

Int J Mol Sci. 2016 Oct 22;17(10). pii: E1768.

29.

CB2-63 polymorphism and immune-mediated diseases associated with HCV chronic infection.

Coppola N, Zampino R, Bellini G, Stanzione M, Capoluongo N, Marrone A, Macera M, Adinolfi LE, Giudice EM, Gentile I, Sagnelli E, Rossi F.

Dig Liver Dis. 2016 Nov;48(11):1364-1369. doi: 10.1016/j.dld.2016.07.005. Epub 2016 Jul 15.

PMID:
27476469
30.

Boceprevir or telaprevir in hepatitis C virus chronic infection: The Italian real life experience.

Cleo Study Group, Ascione A, Adinolfi LE, Amoroso P, Andriulli A, Armignacco O, Ascione T, Babudieri S, Barbarini G, Brogna M, Cesario F, Citro V, Claar E, Cozzolongo R, D'Adamo G, D'Amico E, Dattolo P, De Luca M, De Maria V, De Siena M, De Vita G, Di Giacomo A, De Marco R, De Stefano G, De Stefano G, Di Salvo S, Di Sarno R, Farella N, Felicioni L, Fimiani B, Fontanella L, Foti G, Furlan C, Giancotti F, Giolitto G, Gravina T, Guerrera B, Gulminetti R, Iacobellis A, Imparato M, Iodice A, Iovinella V, Izzi A, Liberti A, Leo P, Lettieri G, Luppino I, Marrone A, Mazzoni E, Messina V, Monarca R, Narciso V, Nosotti L, Pellicelli AM, Perrella A, Piai G, Picardi A, Pierri P, Pietromatera G, Resta F, Rinaldi L, Romano M, Rossini A, Russello M, Russo G, Sacco R, Sangiovanni V, Schiano A, Sciambra A, Scifo G, Simeone F, Sullo A, Tarquini P, Tundo P, Vallone A.

World J Hepatol. 2016 Aug 8;8(22):949-56. doi: 10.4254/wjh.v8.i22.949.

31.

HBsAg kinetics in chronic hepatitis D during interferon therapy: on-treatment prediction of response.

Niro GA, Smedile A, Fontana R, Olivero A, Ciancio A, Valvano MR, Pittaluga F, Coppola N, Wedemeyer H, Zachou K, Marrone A, Fasano M, Lotti G, Andreone P, Iacobellis A, Andriulli A, Rizzetto M.

Aliment Pharmacol Ther. 2016 Sep;44(6):620-8. doi: 10.1111/apt.13734. Epub 2016 Jul 22.

32.

NAFLD and NASH in HCV Infection: Prevalence and Significance in Hepatic and Extrahepatic Manifestations.

Adinolfi LE, Rinaldi L, Guerrera B, Restivo L, Marrone A, Giordano M, Zampino R.

Int J Mol Sci. 2016 May 25;17(6). pii: E803. doi: 10.3390/ijms17060803. Review.

33.

Posterior Reversible Encephalopathy Syndrome: Clinical Differences in Patients with Exclusive Involvement of Posterior Circulation Compared to Anterior or Global Involvement.

Marrone LCP, Martins WA, Borges MT, Rossi BC, Brunelli JPF, Vedana VM, Missima N, Soder RB, Marrone ACH, da Costa JC.

J Stroke Cerebrovasc Dis. 2016 Jul;25(7):1776-1780. doi: 10.1016/j.jstrokecerebrovasdis.2016.03.042. Epub 2016 Apr 18.

PMID:
27103268
34.

Activation and Reactivity of a Bispidine Analogue of Cisplatin: A Theoretical Investigation.

Graziani V, Coletti C, Marrone A, Re N.

J Phys Chem A. 2016 Jul 14;120(27):5175-86. doi: 10.1021/acs.jpca.6b00844. Epub 2016 Apr 22.

PMID:
27070849
35.

MicroRNA changes, activation of progenitor cells and severity of liver injury in mice induced by choline and folate deficiency.

Tryndyak VP, Marrone AK, Latendresse JR, Muskhelishvili L, Beland FA, Pogribny IP.

J Nutr Biochem. 2016 Feb;28:83-90. doi: 10.1016/j.jnutbio.2015.10.001. Epub 2015 Oct 21.

PMID:
26878785
36.

Holmes' tremor as a delayed complication of thalamic stroke.

Martins WA, Marrone LC, Fussiger H, Vedana VM, Cristovam Rdo A, Taietti MZ, Marrone AC.

J Clin Neurosci. 2016 Apr;26:158-9. doi: 10.1016/j.jocn.2015.09.014. Epub 2015 Nov 19.

PMID:
26778811
37.

MicroRNA Responses to the Genotoxic Carcinogens Aflatoxin B1 and Benzo[a]pyrene in Human HepaRG Cells.

Marrone AK, Tryndyak V, Beland FA, Pogribny IP.

Toxicol Sci. 2016 Feb;149(2):496-502. doi: 10.1093/toxsci/kfv253. Epub 2015 Nov 24.

PMID:
26609139
38.

Renal stromal miRNAs are required for normal nephrogenesis and glomerular mesangial survival.

Phua YL, Chu JY, Marrone AK, Bodnar AJ, Sims-Lucas S, Ho J.

Physiol Rep. 2015 Oct;3(10). pii: e12537. doi: 10.14814/phy2.12537.

39.

Risk factors for carotid atherosclerosis in chronic hepatitis C: no role of the APOC3 variant.

Zampino R, Florio A, Grandone A, Capoluongo N, Marrone A, Minichini C, Adinolfi LE, Miraglia del Giudice E, Coppola N.

Infez Med. 2015 Sep;23(3):285-7. No abstract available.

40.

Role of ITPA and IL28B variants in the management of chronic hepatitis C treatment.

Zampino R, Alessio L, Marrone A, Stanzione M, Boemio A, Grandone A, Minichini C, Pisaturo M, Starace M, Adinolfi LE, Sagnelli E, Coppola N.

Infez Med. 2015 Jun;23(2):134-9.

41.

Investigation of the molecular similarity in closely related protein systems: The PrP case study.

Storchi L, Paciotti R, Re N, Marrone A.

Proteins. 2015 Oct;83(10):1751-65. doi: 10.1002/prot.24836. Epub 2015 Aug 6.

PMID:
26018750
42.

Patatin-Like Phospholipase Domain-Containing 3 I148M Variant Is Associated with Liver Steatosis and Fat Distribution in Chronic Hepatitis B.

Zampino R, Coppola N, Cirillo G, Boemio A, Grandone A, Stanzione M, Capoluongo N, Marrone A, Macera M, Sagnelli E, Adinolfi LE, del Giudice EM.

Dig Dis Sci. 2015 Oct;60(10):3005-10. doi: 10.1007/s10620-015-3716-7. Epub 2015 May 19.

PMID:
25986529
43.

Differentially expressed MicroRNAs provide mechanistic insight into fibrosis-associated liver carcinogenesis in mice.

Marrone AK, Shpyleva S, Chappell G, Tryndyak V, Uehara T, Tsuchiya M, Beland FA, Rusyn I, Pogribny IP.

Mol Carcinog. 2016 May;55(5):808-17. doi: 10.1002/mc.22323. Epub 2015 Apr 11.

PMID:
25865624
44.

The impact of the CB2-63 polymorphism on the histological presentation of chronic hepatitis B.

Coppola N, Zampino R, Bellini G, Stanzione M, Capoluongo N, Marrone A, Macera M, Pasquale G, Boemio A, Maione S, Adinolfi LE, Del Giudice EM, Sagnelli E, Rossi F.

Clin Microbiol Infect. 2015 Jun;21(6):609.e1-4. doi: 10.1016/j.cmi.2015.02.021. Epub 2015 Mar 5.

45.

TiCl4-promoted condensation of methyl acetoacetate, isobutyraldehyde, and indole: a theoretical and experimental study.

Renzetti A, Marrone A, Gérard S, Sapi J, Nakazawa H, Re N, Fontana A.

Phys Chem Chem Phys. 2015 Apr 14;17(14):8964-72. doi: 10.1039/c4cp05412a. Epub 2015 Mar 9.

PMID:
25746215
46.

Chronic hepatitis C virus infection and neurological and psychiatric disorders: an overview.

Adinolfi LE, Nevola R, Lus G, Restivo L, Guerrera B, Romano C, Zampino R, Rinaldi L, Sellitto A, Giordano M, Marrone A.

World J Gastroenterol. 2015 Feb 28;21(8):2269-80. doi: 10.3748/wjg.v21.i8.2269. Review.

47.

The role for microRNAs in drug toxicity and in safety assessment.

Marrone AK, Beland FA, Pogribny IP.

Expert Opin Drug Metab Toxicol. 2015 Apr;11(4):601-11. doi: 10.1517/17425255.2015.1021687. Epub 2015 Mar 5. Review.

PMID:
25739314
48.

Suppression of CYP2C9 by microRNA hsa-miR-128-3p in human liver cells and association with hepatocellular carcinoma.

Yu D, Green B, Marrone A, Guo Y, Kadlubar S, Lin D, Fuscoe J, Pogribny I, Ning B.

Sci Rep. 2015 Feb 23;5:8534. doi: 10.1038/srep08534.

49.

TM6SF2 E167K variant is associated with severe steatosis in chronic hepatitis C, regardless of PNPLA3 polymorphism.

Coppola N, Rosa Z, Cirillo G, Stanzione M, Macera M, Boemio A, Grandone A, Pisaturo M, Marrone A, Adinolfi LE, Sagnelli E, Miraglia del Giudice E.

Liver Int. 2015 Aug;35(8):1959-63. doi: 10.1111/liv.12781. Epub 2015 Jan 27.

PMID:
25581573
50.

Epstein Barr virus infection reactivation as a possible trigger of primary biliary cirrhosis-like syndrome in a patient with multiple sclerosis in the course of fingolimod treatment.

Marrone A, Signoriello E, Alfieri G, Dalla Mora L, Rinaldi L, Rainone I, Adinolfi LE, Lus G.

Infez Med. 2014 Dec;22(4):331-6.

Supplemental Content

Loading ...
Support Center